Peer Review reports
From: Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor types
| Original Submission | ||
|---|---|---|
| 26 Oct 2022 | Submitted | Original manuscript |
| 7 Dec 2022 | Reviewed | Reviewer Report |
| 9 Dec 2022 | Reviewed | Reviewer Report |
| 12 Dec 2022 | Reviewed | Reviewer Report |
| 22 Jan 2023 | Author responded | Author comments - Yaping Ma |
| Resubmission - Version 2 | ||
| 22 Jan 2023 | Submitted | Manuscript version 2 |
| 23 Jan 2023 | Author responded | Author comments - Yaping Ma |
| Resubmission - Version 3 | ||
| 23 Jan 2023 | Submitted | Manuscript version 3 |
| 2 Feb 2023 | Reviewed | Reviewer Report |
| 21 Feb 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 15 Mar 2023 | Editorially accepted | |
| 27 Mar 2023 | Article published | 10.1186/s12920-023-01489-9 |
You can find further information about peer review here.